How strong was your desire for nonsweet tasty foods (French fries, potato chips, hamburgers, pizza)
Recent clinical trials and meta-analyses from 2022 to 2025 show significant results validating the efficacy and safety of this medication for weight loss
Specialty practices managing high volumes of GLP-1, biologic, or specialty injectable prescriptions need a dedicated function, not a shared administrative task
Managing blood sugar can help support kidney function, too so much so that in January 2025, the U.S
Orforglipron (Foundayo) approved April 2026, the first once-daily GLP-1 pill with no food or water restrictions
Selective stimulation with minimal stress-hormone impact: Earlier growth hormone releasing peptides were associated with increased cortisol or prolactin levels